NasdaqGS - Delayed Quote USD
AnaptysBio, Inc. (ANAB)
21.86
-0.37
(-1.66%)
At close: June 2 at 4:00:01 PM EDT
21.86
0.00
(0.00%)
After hours: June 2 at 6:53:45 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-108,784
-135,337
-120,800
-73,593
-45,920
Investing Cash Flow
41,629
95,398
144,754
-394,845
38,835
Financing Cash Flow
112,097
127,054
-59,297
44,017
252,298
End Cash Position
98,637
123,080
35,965
71,308
495,729
Interest Paid Supplemental Data
--
--
--
0
0
Capital Expenditure
-366
-358
-807
-358
-1,366
Issuance of Capital Stock
100,321
100,842
2,472
11,827
2,553
Repayment of Debt
--
--
--
0
0
Repurchase of Capital Stock
-4,880
-456
-50,000
0
0
Free Cash Flow
-109,150
-135,695
-121,607
-73,951
-47,286
12/31/2021 - 1/26/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MBX MBX Biosciences, Inc.
13.14
+5.80%
KURA Kura Oncology, Inc.
6.30
+10.72%
AGIO Agios Pharmaceuticals, Inc.
32.63
+1.68%
EWTX Edgewise Therapeutics, Inc.
14.69
+2.87%
ELVN Enliven Therapeutics, Inc.
19.14
+7.71%
BCAX Bicara Therapeutics Inc.
9.90
+7.03%
ANNX Annexon, Inc.
2.1200
+3.92%
OLMA Olema Pharmaceuticals, Inc.
4.3750
-17.14%
CGEM Cullinan Therapeutics, Inc.
8.75
+1.21%
TRML Tourmaline Bio, Inc.
17.11
+2.58%